Patents

US 10955416 B2: Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer

Granted
2021-03-23
Filed
2018-02-16 application 15898275
Type
Utility · 9 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Novel gene deletions and translocations involving chromosome 2 resulting in fusion proteins combining part of Anaplastic Lymphoma Kinase (ALK) kinase with part of a secondary protein have now been identified in human solid tumors, e.g. non-small cell lung carcinoma (NSCLC). Secondary proteins include Echinoderm Microtubule-Associated Protein-Like 4 (EML-4) and TRK-Fusion Gene (TFG). The EML4-ALK fusion protein, which retains ALK tyrosine kinase activity, was confirmed to drive the proliferation and survival of NSCLC characterized by this mutation. The invention therefore provides, in part, isolated polynucleotides and vectors encoding the disclosed mutant polypeptides, probes for detecting it, isolated mutant polypeptides, and reagents for detecting the fusion and truncated polypeptides. The invention also provides methods for determining the presence of these mutant polypeptides in a biological sample, methods for screening for compounds that inhibit the proteins, and methods for inhibiting the progression of a cancer characterized by the mutant polynucleotides or polypeptides.

Source: PVGPATDIS, file of 2026-04-10 (ipg210323.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CELL SIGNALING TECHNOLOGY, INC. 49 patentsUS company or organizationDanvers, MAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Klarisa RikovaReading, MA27PVGPATDIS, file of 2026-04-10
Herbert HaackHamilton, MA18PVGPATDIS, file of 2026-04-10
Laura SullivanShrewsbury, MA14PVGPATDIS, file of 2026-04-10
Ailan GuoLexington, MA31PVGPATDIS, file of 2026-04-10
Anthony PossematoWorcester, MA17PVGPATDIS, file of 2026-04-10
Joan MacNeillLitchfield, NH12PVGPATDIS, file of 2026-04-10
Ting-Lei GuWoburn, MA21PVGPATDIS, file of 2026-04-10
Jian YuHamilton, MA24PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/575PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N9/1205PVGPATDIS, file of 2026-04-10
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/6886PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K38/00PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K2319/00PVGPATDIS, file of 2026-04-10
Y10TTechnical subjects covered by former us classificationY10T436/117497PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.